By Ben Aris in Berlin Cyclical industries across Europe are in danger from the economic slowdown sweeping Europe, Goldman Sachs warned in a note on February 4. The polycrisis that has hit the region ...

Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.

Sippican Capital Advisors purchased a new stake in Alphabet Inc. (NASDAQ:GOOGL – Free Report) during the fourth quarter, ...

KBC Group NV raised its holdings in PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) by 36.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned ...

A government blunder and TV woes have helped lift the company’s stock 54% in the past year. How to play it now.

Invesco High Yield Equity Dividend Achievers (PEY) is a defensive fund with strong dividend growth and potential value ...

We recently compiled a list of the 10 Best Rebound Stocks To Invest In Now. In this article, we are going to take a look at ...

Defiance S&P 500 Target Income ETF offers high yield but limits upside potential. See why SPYT may underperform compared to ...